Seven-year Trends in Visual Acuity at First Presentation in Patients with Neovascular AMD

Ophthalmology. 2017 Feb;124(2):270-272. doi: 10.1016/j.ophtha.2016.08.013. Epub 2016 Sep 3.
No abstract available

Publication types

  • Review

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage*
  • Disease Progression
  • Follow-Up Studies
  • Humans
  • Intravitreal Injections
  • Prognosis
  • Time Factors
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*
  • Visual Acuity / physiology*
  • Wet Macular Degeneration* / diagnosis
  • Wet Macular Degeneration* / drug therapy
  • Wet Macular Degeneration* / physiopathology

Substances

  • Angiogenesis Inhibitors
  • Vascular Endothelial Growth Factor A